RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PUGLIESE N
Collezione AOU Novara

Items : 6

Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine. in JHEP reports : innovation in hepatology / JHEP Rep. 2023 Sep 15;6(1):100910. doi: 10.1016/j.jhepr.2023.100910. eCollection 2024 Jan.

2024
AOU Novara

Polidoro MA; Ferrari E; Soldani C; Franceschini B; Saladino G; Rosina A; Mainardi A; D'Autilia F; Pugliese N; Costa G; Donadon M; Torzilli G; Marzorati S; Rasponi M; Lleo A;

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. in European journal of haematology / Eur J Haematol. 2023 Apr;110(4):354-361. doi: 10.1111/ejh.13910. Epub 2022 Dec 16.

2023
AOU Città della Salute di Torino
AOU Novara

Elli EM; Antolini L; Gambacorti-Passerini C; Montelisciani L; Martinelli V; Lanzarone G; Castelli A; Pugliese N; Civettini I; Crisà E; Inzoli E;

Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry. in ESC heart failure / ESC Heart Fail. 2023 Apr;10(2):846-857. doi: 10.1002/ehf2.14155. Epub 2022 Nov 29.

2023
AOU Novara

Mandoli GE; Pastore MC; Giannoni A; Benfari G; Dini FL; Rosa G; Pugliese NR; Taddei C; Correale M; Brunetti ND; Mazzeo P; Carluccio E; Mengoni A; Guaricci AI; Piscitelli L; Citro R; Ciccarelli M; Novo G; Corrado E; Pasquini A; Loria V; De Carli G; Degiovanni A; Patti G; Santoro C; Moderato L; Cicoira M; Canepa M; Malagoli A; et alii...

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register. in European heart journal open / Eur Heart J Open. 2021 Dec 21;2(1):oeab046. doi: 10.1093/ehjopen/oeab046. eCollection 2022 Jan.

2022
AOU Novara

Mandoli GE; Pastore MC; Giannoni A; Benfari G; Dini FL; Pugliese NR; Taddei C; Correale M; Brunetti ND; Carluccio E; Mengoni A; Guaricci AI; Piscitelli L; Citro R; Ciccarelli M; Novo G; Corrado E; Pasquini A; Loria V; Degiovanni A; Patti G; Santoro C; Moderato L; Malagoli A; Emdin M; Cameli M; Rosa G; Magnesa M; Mazzeo P; et alii...

Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study. in British journal of haematology / Br J Haematol. 2022 Apr;197(2):190-200. doi: 10.1111/bjh.18057. Epub 2022 Feb 8.

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palandri F; Latagliata R; Palumbo GA; Bucelli C; Gambacorti-Passerini C; Breccia M; Biale L; Scaffidi L; Renso R; Auteri G; Cattaneo D; Trawinska MM; Porrini R; Markovic U; Pugliese N; Caocci G; Crisà E; Tiribelli M; Cilloni D; Caramella M; Abruzzese E; Bonifacio M; Bergamaschi M; Polverelli N; Elli EM; Di Veroli A; Bartoletti D; Iurlo A; Carmosino I; et alii...

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.

2018
ASL Asti
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Ferrero D; Boccadoro M; Mezzabotta M; Marchetti M; Lanzarone G; Cerrano M; Frairia C; Pugliese N; Beggiato E; Martinelli V; Palumbo GA; Elli EM; Cilloni D; Crisà E;